Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus

被引:142
作者
Gergely, P
Niland, B
Gonchoroff, N
Pullmann, R
Phillips, PE
Perl, A
机构
[1] SUNY Syracuse, Dept Med, Coll Med, Syracuse, NY 13210 USA
[2] SUNY Syracuse, Dept Microbiol & Immunol, Coll Med, Syracuse, NY 13210 USA
[3] SUNY Syracuse, Dept Pathol, Coll Med, Syracuse, NY 13210 USA
关键词
D O I
10.4049/jimmunol.169.2.1092
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Abnormal death signaling in lymphocytes of systemic lupus erythematosus (SLE) patients has been associated with elevation of the mitochondrial transmembrane potential (DeltaPsi(m)) and increased production of reactive oxygen intermediates (1101). The resultant ATP depletion sensitizes T cells for necrosis that may significantly contribute to inflammation in patients with SLE. In the present study, the role of mitochondrial signal processing in T cell activation was investigated. CD3/CD28 costimulation of PBL elicited transient mitochondrial hyperpolarization and intracellular pH (pH(i)) elevation, followed by increased ROI production. Baseline DeltaPsi(m), ROI production, and pH(i) were elevated, while T cell activation-induced changes were blunted in 15 patients with SLE in comparison with 10 healthy donors and 10 rheumatoid arthritis patients. Similar to CD3/CD28 costimulation, treatment of control PBL with IL-3, IL-10, TGF-beta(1), and IFN-gamma led to transient DeltaPsi(m) elevation. IL-10 had diametrically opposing effects on mitochondrial signaling in lupus and control donors. Unlike healthy or rheumatoid arthritis PBL, cells of lupus patients were resistant to IL-10-induced mitochondrial hyperpolarization. By contrast, IL-10 enhanced ROI production and cell death in lupus PBL without affecting ROI levels and survival of control PBL. Ab-mediated IL-10 blockade or stimulation with antagonistic lymphokine IL-12 normalized baseline and CD3/CD28-induced changes in ROI production and pH(i) with no impact on At. of lupus PBL. The results suggest that mitochondrial hyperpolarization, increased ROI production, and cytoplasmic alkalinization play crucial roles in altered IL-10 responsiveness in SLE.
引用
收藏
页码:1092 / 1101
页数:10
相关论文
共 63 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression [J].
Banki, K ;
Hutter, E ;
Colombo, E ;
Gonchoroff, NJ ;
Perl, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32994-33001
[3]  
Banki K, 1999, J IMMUNOL, V162, P1466
[4]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[5]   AUTOANTIGENS TARGETED IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE CLUSTERED IN 2 POPULATIONS OF SURFACE-STRUCTURES ON APOPTOTIC KERATINOCYTES [J].
CASCIOLAROSEN, LA ;
ANHALT, G ;
ROSEN, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1317-1330
[6]  
COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411
[7]   PROTECTIVE EFFECT OF N-ACETYLCYSTEINE IN TUMOR NECROSIS FACTOR-ALPHA-INDUCED APOPTOSIS IN U937 CELLS - THE ROLE OF MITOCHONDRIA [J].
COSSARIZZA, A ;
FRANCESCHI, C ;
MONTI, D ;
SALVIOLI, S ;
BELLESIA, E ;
RIVABENE, R ;
BIONDO, L ;
RAINALDI, G ;
TINARI, A ;
MALORNI, W .
EXPERIMENTAL CELL RESEARCH, 1995, 220 (01) :232-240
[8]  
ELKON KB, 1994, CLIN EXP RHEUMATOL, V12, P553
[9]  
EMLEN W, 1994, J IMMUNOL, V152, P3685
[10]   More than one way to die: apoptosis, necrosis and reactive oxygen damage [J].
Fiers, W ;
Beyaert, R ;
Declercq, W ;
Vandenabeele, P .
ONCOGENE, 1999, 18 (54) :7719-7730